Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Long-Term Investments (2021 - 2022)

Biote (BTMD) has 2 years of Long-Term Investments data on record, last reported at $317.6 million in Q1 2022.

  • For Q1 2022, Long-Term Investments changed 0.02% year-over-year to $317.6 million; the TTM value through Mar 2022 reached $317.6 million, changed 0.02%, while the annual FY2021 figure was $317.6 million, N/A changed from the prior year.
  • Long-Term Investments reached $317.6 million in Q1 2022 per BTMD's latest filing, roughly flat from $317.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $317.6 million in Q1 2022 and bottomed at $317.5 million in Q2 2021.